TherapeuticsMD (TXMD) Price to Book (2011 - 2026)

TherapeuticsMD (TXMD) has reported Price to Book for 16 consecutive years, with 0.94 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 91.64% year-over-year to 0.94; the trailing twelve-month figure through Jun 2026 stood at 0.94 (up 91.64% YoY), and the FY2025 full-year result was 0.7, up 93.72% from the prior year.
• Price to Book climbed to 0.94 in Q2 2026 per TXMD's latest filing, from 0.87 in the prior quarter.
• Across five years, Price to Book topped out at 1.51 in Q4 2022 and bottomed at 3.38 in Q2 2022.
• Historically, Price to Book has averaged 0.37 across 5 years, with a median of 0.7 in 2024.
• The sharpest annual moves came in 2023 and 2024: Price to Book surged 195.43% in 2023, then tumbled 59.1% in 2024.
• Over 5 years, Price to Book stood at 1.51 in 2022, then tumbled by 41.36% to 0.89 in 2023, then tumbled by 59.1% to 0.36 in 2024, then soared by 93.72% to 0.7 in 2025, then surged by 34.3% to 0.94 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 0.94, 0.87, and 0.7 for Q2 2026, Q1 2026, and Q4 2025 respectively.